CATEGORY | N (147) | AHFS | CP | DIO | DM | EOF | EOP | FC | IDI | JHAG | LC | LC-AHFS | MDR | MM | PPDC |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dosing | 15 | 12 | 11 | 12 | 10 | 6 | 6 | 12 | 12 | 8 | 12 | 12 | 12 | 13 | 6 |
Indication | 15 | 13 | 11 | 11 | 5 | 6 | 6 | 9 | 7 | 11 | 13 | 13 | 14 | 15 | 7 |
Adverse Reaction/Event | 13 | 9 | 12 | 8 | 10 | 6 | 6 | 11 | 11 | 8 | 8 | 9 | 9 | 11 | 4 |
Contraindications | 13 | 12 | 9 | 10 | 8 | 8 | 8 | 9 | 8 | 5 | 11 | 12 | 10 | 12 | 5 |
Drug-Drug Interactions | 12 | 11 | 12 | 10 | 10 | 11 | 11 | 10 | 10 | 6 | 10 | 11 | 12 | 10 | 10 |
Emerging Resistance | 12 | 8 | 9 | 4 | 10 | 0 | 0 | 9 | 10 | 6 | 2 | 8 | 9 | 10 | 0 |
Administration | 10 | 10 | 8 | 8 | 8 | 6 | 6 | 10 | 10 | 7 | 9 | 10 | 10 | 9 | 4 |
Mechanism of Action | 9 | 8 | 9 | 8 | 6 | 8 | 8 | 9 | 7 | 7 | 7 | 8 | 8 | 7 | 7 |
Food-Drug Interactions | 7 | 7 | 5 | 4 | 4 | 2 | 2 | 4 | 4 | 3 | 4 | 7 | 5 | 4 | 2 |
Compatibility/Stability | 7 | 4 | 4 | 0 | 3 | 0 | 0 | 4 | 4 | 0 | 3 | 4 | 5 | 4 | 0 |
Spectrum of Activity | 7 | 5 | 6 | 4 | 5 | 3 | 3 | 5 | 5 | 6 | 4 | 5 | 5 | 7 | 4 |
Pregnancy/Lactation | 7 | 5 | 7 | 6 | 5 | 5 | 5 | 6 | 6 | 5 | 5 | 7 | 6 | 6 | 5 |
Synergy | 6 | 6 | 5 | 4 | 5 | 3 | 3 | 5 | 4 | 4 | 3 | 6 | 6 | 6 | 3 |
Drug-Herb Interactions | 5 | 2 | 2 | 1 | 2 | 0 | 2 | 1 | 2 | 1 | 1 | 2 | 2 | 3 | 2 |
Cost | 5 | 0 | 0 | 3 | 0 | 2 | 2 | 0 | 0 | 3 | 2 | 2 | 3 | 0 | 0 |
Pharmacokinetics | 4 | 3 | 3 | 3 | 4 | 1 | 1 | 4 | 4 | 2 | 2 | 3 | 3 | 4 | 1 |
Percent Answered (%) | Â | 78 | 77 | 65 | 65 | 46 | 47 | 73 | 71 | 56 | 65 | 81 | 81 | 82 | 41 |